Action 300957 YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Yunnan Botanee Bio-Technology Group Co.LTD

Actions

300957

CNE100004G74

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
52,21 CNY -1,32 % Graphique intraday de Yunnan Botanee Bio-Technology Group Co.LTD -2,23 % -23,41 %
29/04 YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD : Jefferies & Co. maintient son opinion neutre ZM
25/04 Yunnan Botanee Bio-Technology Group Co.LTD publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Yunnan Botanee Bio-Technology Group Co.LTD Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 11 June 2024
Yunnan Botanee Bio-Technology Group Co.LTD Approves Cash Dividend for the Year 2023
Yunnan Botanee Bio-Technology Group Co.LTD Proposes Final Dividend for 2023
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2024
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.
Certain A Shares of Yunnan Botanee Bio-Technology Group Co.LTD are subject to a Lock-Up Agreement Ending on 25-MAR-2024.
Weimai Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Yunnan Botanee Bio-Technology Group Co.LTD
Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.
In China's slowing beauty market, big brand discounts won't cut it
Shanghai Weimu Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd., SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd.
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2023
Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback.
Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD
Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares.
Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan.
Yunnan Botanee’s H1 Profit Jumps 14% as Revenue Grows 15.5%
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Ruishi Health Technology Co., Ltd. announced that it has received CNY 100 million in funding from BRV Partners, LLC, Yaojin Private Equity Fund Management Co., Ltd., Sinovation Ventures Enterprise Management Limited, Yunnan Botanee Bio-Technology Group Co.LTD
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300957
  4. Actualités Yunnan Botanee Bio-Technology Group Co.LTD
  5. Autres langues